{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T13:35:36Z","timestamp":1775568936996,"version":"3.50.1"},"reference-count":72,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012155","name":"National Institute for Medical Research Development","doi-asserted-by":"publisher","award":["943609"],"award-info":[{"award-number":["943609"]}],"id":[{"id":"10.13039\/501100012155","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.clnu.2019.02.006","type":"journal-article","created":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T15:00:08Z","timestamp":1549810808000},"page":"331-342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Plant-derived natural agents as dietary supplements for the regulation of glycosylated hemoglobin: A review of clinical trials"],"prefix":"10.1016","volume":"39","author":[{"given":"Elnaz","family":"Rezaeiamiri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roodabeh","family":"Bahramsoltani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8637-4350","authenticated-orcid":false,"given":"Roja","family":"Rahimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnu.2019.02.006_bib1","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet Med"},{"key":"10.1016\/j.clnu.2019.02.006_bib2","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","article-title":"Global prevalence of diabetes: estimates for the year 2000 and projections for 2030","volume":"27","author":"Wild","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clnu.2019.02.006_bib3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S2213-8587(13)70112-8","article-title":"Diabetes: a 21st century challenge","volume":"2","author":"Zimmet","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.clnu.2019.02.006_bib4","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.2337\/dc14-S081","article-title":"Diagnosis and classification of diabetes mellitus","volume":"37","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clnu.2019.02.006_bib5","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc16-S005","article-title":"Classification and diagnosis of diabetes","volume":"39","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clnu.2019.02.006_bib6","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJM199306103282306","article-title":"Long-term complications of diabetes mellitus","volume":"328","author":"Nathan","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clnu.2019.02.006_bib7","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1586\/14737159.2016.1133299","article-title":"Standardising HbA1c-based diabetes diagnosis: opportunities and challenges","volume":"16","author":"Jia","year":"2016","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.clnu.2019.02.006_bib8","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.2337\/dc15-1188","article-title":"Long-term glycemic variability and risk of adverse outcomes: a systematic review and meta-analysis","volume":"38","author":"Gorst","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clnu.2019.02.006_bib9","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/164_2015_7","article-title":"Current and emerging treatment options in diabetes care","volume":"233","author":"Clemmensen","year":"2016","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.clnu.2019.02.006_bib10","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.19082\/1832","article-title":"The role of medicinal plants in the treatment of diabetes: a systematic review","volume":"8","author":"Kooti","year":"2016","journal-title":"Electron Physician"},{"key":"10.1016\/j.clnu.2019.02.006_bib11","series-title":"Randomised Controlled Trials: questions, answers and musings","author":"Jadad","year":"2007"},{"key":"10.1016\/j.clnu.2019.02.006_bib12","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1007\/s00018-008-7452-4","article-title":"Curcumin: from ancient medicine to current clinical trials","volume":"65","author":"Hatcher","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.clnu.2019.02.006_bib13","first-page":"131","article-title":"Clinical applications of curcumin","volume":"3","author":"Sunagawa","year":"2015","journal-title":"Pharm Nutr"},{"key":"10.1016\/j.clnu.2019.02.006_bib14","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jad.2014.06.001","article-title":"Curcumin for the treatment of major depression: a randomised, double-blind, placebo controlled study","volume":"167","author":"Lopresti","year":"2014","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.clnu.2019.02.006_bib15","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/mnfr.201200131","article-title":"Curcuminoids exert glucose-lowering effect in type 2 diabetes by decreasing serum free fatty acids: a double-blind, placebo-controlled trial","volume":"57","author":"Na","year":"2013","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.clnu.2019.02.006_bib16","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.numecd.2009.11.009","article-title":"Curcumin improves insulin resistance in skeletal muscle of rats","volume":"21","author":"Na","year":"2011","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.clnu.2019.02.006_bib17","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2165\/00126839-200809040-00004","article-title":"Effect of NCB-02, atorvastatin and placebo on endothelial function, oxidative stress and inflammatory markers in patients with type 2 diabetes mellitus: a randomized, parallel-group, placebo-controlled, 8-week study","volume":"9","author":"Usharani","year":"2008","journal-title":"Drugs R"},{"key":"10.1016\/j.clnu.2019.02.006_bib18","doi-asserted-by":"crossref","first-page":"T61","DOI":"10.1530\/JOE-13-0397","article-title":"Fatty acid metabolism, energy expenditure and insulin resistance in muscle","volume":"220","author":"Turner","year":"2014","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.clnu.2019.02.006_bib19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4143\/crt.2014.46.1.2","article-title":"Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: the golden pigment from golden spice","volume":"46","author":"Prasad","year":"2014","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.clnu.2019.02.006_bib20","first-page":"567","article-title":"The effect of nano-curcumin on HbA1c, fasting blood glucose, and lipid profile in diabetic subjects: a randomized clinical trial","volume":"6","author":"Rahimi","year":"2016","journal-title":"Avicenna J Phytomed"},{"key":"10.1016\/j.clnu.2019.02.006_bib21","doi-asserted-by":"crossref","first-page":"E191","DOI":"10.3390\/molecules22020191","article-title":"Silymarin\/silybin and chronic liver disease: a marriage of many years","volume":"22","author":"Federico","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.clnu.2019.02.006_bib22","first-page":"916","article-title":"Protective effect of silymarin against chemical-induced cardiotoxicity","volume":"19","author":"Razavi","year":"2016","journal-title":"Iran J Basic Med Sci"},{"key":"10.1016\/j.clnu.2019.02.006_bib23","first-page":"5147468","article-title":"Silymarin in type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials","volume":"2016","author":"Voroneanu","year":"2016","journal-title":"J\u00a0Diabetes Res"},{"key":"10.1016\/j.clnu.2019.02.006_bib24","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0168-8278(97)80255-3","article-title":"Long-term (12 months) treatment with an anti-oxidant drug (silymarin) is effective on hyperinsulinemia, exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients","volume":"26","author":"Velussi","year":"1997","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clnu.2019.02.006_bib25","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/ptr.1988","article-title":"The efficacy of Silybum marianum (L.) Gaertn. (silymarin) in the treatment of type II diabetes: a randomized, double-blind, placebo-controlled, clinical trial","volume":"20","author":"Huseini","year":"2006","journal-title":"Phytother Res"},{"key":"10.1016\/j.clnu.2019.02.006_bib26","first-page":"79","article-title":"The effects of Silybum marianum (L.) Gaertn. seed extract on glycemic control in type II diabetic patient's candidate for insulin therapy visiting endocrinology clinic in Baqiyatallah hospital in the years of 2006","volume":"7","author":"Ramezani","year":"2008","journal-title":"J\u00a0Med Plants"},{"key":"10.1016\/j.clnu.2019.02.006_bib27","first-page":"170","article-title":"Effects of silymarin on insulin resistance and blood lipid profile in first-degree relatives of type 2 diabetic patients","volume":"12","author":"Mohammadi","year":"2013","journal-title":"J\u00a0Med Plants"},{"key":"10.1016\/j.clnu.2019.02.006_bib28","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1089\/jmf.2006.089","article-title":"Silymarin as an adjunct to glibenclamide therapy improves long-term and postprandial glycemic control and body mass index in type 2 diabetes","volume":"10","author":"Hussain","year":"2007","journal-title":"J\u00a0Med Food"},{"key":"10.1016\/j.clnu.2019.02.006_bib29","series-title":"Antioxidants in sport nutrition","article-title":"Well-known antioxidants and newcomers in sport nutrition: coenzyme Q10, quercetin, resveratrol, pterostilbene, pycnogenol and astaxanthin","author":"Belviranli","year":"2015"},{"key":"10.1016\/j.clnu.2019.02.006_bib30","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ptr.5019","article-title":"Pycnogenol(R) in chronic venous insufficiency and related venous disorders","volume":"28","author":"Gulati","year":"2014","journal-title":"Phytother Res"},{"key":"10.1016\/j.clnu.2019.02.006_bib31","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/ptr.5341","article-title":"Pycnogenol(R) in metabolic syndrome and related disorders","volume":"29","author":"Gulati","year":"2015","journal-title":"Phytother Res"},{"key":"10.1016\/j.clnu.2019.02.006_bib32","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1016\/j.lfs.2003.10.043","article-title":"Antidiabetic effect of Pycnogenol French maritime pine bark extract in patients with diabetes type II","volume":"75","author":"Liu","year":"2004","journal-title":"Life Sci"},{"key":"10.1016\/j.clnu.2019.02.006_bib33","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.nutres.2008.03.003","article-title":"Reduction of cardiovascular risk factors in subjects with type 2 diabetes by Pycnogenol supplementation","volume":"28","author":"Zibadi","year":"2008","journal-title":"Nutr Res"},{"key":"10.1016\/j.clnu.2019.02.006_bib34","doi-asserted-by":"crossref","first-page":"839","DOI":"10.2337\/diacare.27.3.839","article-title":"French maritime pine bark extract Pycnogenol dose-dependently lowers glucose in type 2 diabetic patients","volume":"27","author":"Liu","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clnu.2019.02.006_bib35","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.atherosclerosis.2015.09.032","article-title":"Berberine, a plant alkaloid with lipid- and glucose-lowering properties: from in\u00a0vitro evidence to clinical studies","volume":"243","author":"Pirillo","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clnu.2019.02.006_bib36","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.mce.2014.01.022","article-title":"Berberine attenuates high glucose-induced proliferation and extracellular matrix accumulation in mesangial cells: involvement of suppression of cell cycle progression and NF-\u03baB\/AP-1 pathways","volume":"384","author":"Lan","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.clnu.2019.02.006_bib37","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.metabol.2008.01.013","article-title":"Efficacy of berberine in patients with type 2 diabetes mellitus","volume":"57","author":"Yin","year":"2008","journal-title":"Metabolism"},{"key":"10.1016\/j.clnu.2019.02.006_bib38","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1210\/jc.2007-2404","article-title":"Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine","volume":"93","author":"Zhang","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.clnu.2019.02.006_bib39","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.metabol.2009.07.029","article-title":"Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression","volume":"59","author":"Zhang","year":"2010","journal-title":"Metabolism"},{"key":"10.1016\/j.clnu.2019.02.006_bib40","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.talanta.2010.01.015","article-title":"Effect of traditional Chinese medicine berberine on type 2 diabetes based on comprehensive metabonomics","volume":"81","author":"Gu","year":"2010","journal-title":"Talanta"},{"key":"10.1016\/j.clnu.2019.02.006_bib41","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.2337\/db06-0006","article-title":"Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states","volume":"55","author":"Lee","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.clnu.2019.02.006_bib42","doi-asserted-by":"crossref","first-page":"e0134172","DOI":"10.1371\/journal.pone.0134172","article-title":"Efficacy of berberine in patients with non-alcoholic fatty liver disease","volume":"10","author":"Yan","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.clnu.2019.02.006_bib43","first-page":"9365","article-title":"Berberine ameliorates type 2 diabetes via modulation of Bifidobacterium species, Tumor necrosis factor-\u03b1, and lipopolysaccharide","volume":"9","author":"Chen","year":"2016","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.clnu.2019.02.006_bib44","doi-asserted-by":"crossref","first-page":"E343","DOI":"10.3390\/ijms18020343","article-title":"Effects of a combination of Berberis aristata, Silybum marianum and monacolin on lipid profile in subjects at low cardiovascular risk; a double-blind, randomized, placebo-controlled trial","volume":"18","author":"Derosa","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.clnu.2019.02.006_bib45","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2147\/DMSO.S33718","article-title":"Pilot study on the additive effects of berberine and oral type 2 diabetes agents for patients with suboptimal glycemic control","volume":"5","author":"Di Pierro","year":"2012","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.clnu.2019.02.006_bib46","first-page":"167","article-title":"Preliminary study about the possible glycemic clinical advantage in using a fixed combination of Berberis aristata and Silybum marianum standardized extracts versus only Berberis aristata in patients with type 2 diabetes","volume":"5","author":"Di Pierro","year":"2013","journal-title":"Clin Pharmacol"},{"key":"10.1016\/j.clnu.2019.02.006_bib47","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2147\/DMSO.S78877","article-title":"Clinical role of a fixed combination of standardized Berberis aristata and Silybum marianum extracts in diabetic and hypercholesterolemic patients intolerant to statins","volume":"8","author":"Di Pierro","year":"2015","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.clnu.2019.02.006_bib48","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/jsfa.7147","article-title":"Evaluation of the in\u00a0vitro alpha-glucosidase inhibitory activity of green tea polyphenols and different tea types","volume":"96","author":"Yang","year":"2016","journal-title":"J\u00a0Sci Food Agric"},{"key":"10.1016\/j.clnu.2019.02.006_bib49","doi-asserted-by":"crossref","first-page":"E708","DOI":"10.3390\/molecules21060708","article-title":"Antioxidative and antidiabetic effects of natural polyphenols and isoflavones","volume":"21","author":"Umeno","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.clnu.2019.02.006_bib50","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/oby.2008.505","article-title":"A\u00a0catechin-rich beverage improves obesity and blood glucose control in patients with type 2 diabetes","volume":"17","author":"Nagao","year":"2009","journal-title":"Obesity"},{"key":"10.1016\/j.clnu.2019.02.006_bib51","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/mnfr.201100143","article-title":"Resveratrol and health--a comprehensive review of human clinical trials","volume":"55","author":"Smoliga","year":"2011","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.clnu.2019.02.006_bib52","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.nutres.2012.06.003","article-title":"Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus","volume":"32","author":"Bhatt","year":"2012","journal-title":"Nutr Res"},{"key":"10.1016\/j.clnu.2019.02.006_bib53","doi-asserted-by":"crossref","first-page":"851267","DOI":"10.1155\/2013\/851267","article-title":"Antihyperglycemic effects of short term resveratrol supplementation in type 2 diabetic patients","volume":"2013","author":"Movahed","year":"2013","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.clnu.2019.02.006_bib54","doi-asserted-by":"crossref","first-page":"7862","DOI":"10.1523\/JNEUROSCI.0385-14.2014","article-title":"Effects of resveratrol on memory performance, hippocampal functional connectivity, and glucose metabolism in healthy older adults","volume":"34","author":"Witte","year":"2014","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.clnu.2019.02.006_bib55","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.phrs.2013.03.011","article-title":"One-year supplementation with a grape extract containing resveratrol modulates inflammatory-related microRNAs and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease","volume":"72","author":"Tome-Carneiro","year":"2013","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.clnu.2019.02.006_bib56","doi-asserted-by":"crossref","first-page":"e192","DOI":"10.1016\/j.atherosclerosis.2014.05.566","article-title":"Is long-acting resveratrol effective on the residual dyslipidemia in statin-treated type 2 diabetic patients?","volume":"235","author":"Verges","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clnu.2019.02.006_bib57","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.2337\/db12-0975","article-title":"High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition","volume":"62","author":"Poulsen","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.clnu.2019.02.006_bib58","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3945\/ajcn.115.117440","article-title":"Administration of resveratrol for 5 wk has no effect on glucagon-like peptide 1 secretion, gastric emptying, or glycemic control in type 2 diabetes: a randomized controlled trial","volume":"103","author":"Thazhath","year":"2016","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnu.2019.02.006_bib59","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1123\/ijsnem.2013-0045","article-title":"Effects of resveratrol in patients with type 2 diabetes mellitus on skeletal muscle SIRT1 expression and energy expenditure","volume":"24","author":"Goh","year":"2014","journal-title":"Int J Sport Nutr Exerc Metab"},{"key":"10.1016\/j.clnu.2019.02.006_bib60","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.cmet.2011.10.002","article-title":"Calorie restriction-like effects of 30 days of Resveratrol (resVida\u2122) supplementation on energy metabolism and metabolic profile in obese humans","volume":"14","author":"Timmers","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.clnu.2019.02.006_bib61","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.phrs.2016.08.010","article-title":"Six months of resveratrol supplementation has no measurable effect in type 2 diabetic patients. A randomized, double blind, placebo-controlled trial","volume":"111","author":"Bo","year":"2016","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.clnu.2019.02.006_bib62","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1463-1326.2003.00282.x","article-title":"Effects of dietary supplementation with isoflavones from red clover on ambulatory blood pressure and endothelial function in postmenopausal type 2 diabetes","volume":"5","author":"Howes","year":"2003","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.clnu.2019.02.006_bib63","doi-asserted-by":"crossref","first-page":"e1148","DOI":"10.1371\/journal.pone.0001148","article-title":"Effects of a flaxseed-derived lignan supplement in type 2 diabetic patients: a randomized, double-blind, crossover trial","volume":"2","author":"Pan","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.clnu.2019.02.006_bib64","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1271\/bbb.61.1358","article-title":"Long-term effects of water-soluble corn bran hemicellulose on glucose tolerance in obese and non-obese patients: improved insulin sensitivity and glucose metabolism in obese subjects","volume":"61","author":"Hanai","year":"1997","journal-title":"Biosci Biotechnol Biochem"},{"key":"10.1016\/j.clnu.2019.02.006_bib65","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11655-007-9005-3","article-title":"Clinical observation on trigonella foenum-graecum L. total saponins in combination with sulfonylureas in the treatment of type 2 diabetes mellitus","volume":"14","author":"Lu","year":"2008","journal-title":"Chin J Integr Med"},{"key":"10.1016\/j.clnu.2019.02.006_bib66","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/ajcn\/81.6.1351","article-title":"Plant sterols are efficacious in lowering plasma LDL and non-HDL cholesterol in hypercholesterolemic type 2 diabetic and nondiabetic persons","volume":"81","author":"Lau","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnu.2019.02.006_bib67","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.2040-1124.2011.00101.x","article-title":"Effect of mulberry leaf extract with enriched 1-deoxynojirimycin content on postprandial glycemic control in subjects with impaired glucose metabolism","volume":"2","author":"Asai","year":"2011","journal-title":"J\u00a0Diabetes Investig"},{"key":"10.1016\/j.clnu.2019.02.006_bib68","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.yrtph.2008.02.006","article-title":"Apparent lack of pharmacological effect of steviol glycosides used as sweeteners in humans. A pilot study of repeated exposures in some normotensive and hypotensive individuals and in Type 1 and Type 2 diabetics","volume":"51","author":"Barriocanal","year":"2008","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.clnu.2019.02.006_bib69","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.clnu.2009.03.012","article-title":"Isohumulones, the bitter component of beer, improve hyperglycemia and decrease body fat in Japanese subjects with prediabetes","volume":"28","author":"Obara","year":"2009","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2019.02.006_bib70","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/sj.ejcn.1602081","article-title":"Effects of pinitol isolated from soybeans on glycaemic control and cardiovascular risk factors in Korean patients with type II diabetes mellitus: a randomized controlled study","volume":"59","author":"Kim","year":"2005","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.clnu.2019.02.006_bib71","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1177\/1932296816659885","article-title":"Glycated hemoglobin, plasma glucose, and erythrocyte aging","volume":"10","author":"Beltran Del Rio","year":"2016","journal-title":"J\u00a0Diabetes Sci Technol"},{"key":"10.1016\/j.clnu.2019.02.006_bib72","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.phymed.2015.11.009","article-title":"Role of phytochemicals in the management of metabolic syndrome","volume":"23","author":"Cicero","year":"2016","journal-title":"Phytomedicine"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561419300585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561419300585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:54:17Z","timestamp":1759366457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561419300585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0261561419300585"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2019.02.006","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plant-derived natural agents as dietary supplements for the regulation of glycosylated hemoglobin: A review of clinical trials","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2019.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.","name":"copyright","label":"Copyright"}]}}